Friday September 21, 2018 15:20

Food and Healthcare Press Releases

Future Health Index, Commissioned by Philips, Identifies Key Recommendations for Better Health Heathcare—20 Sep 18

Royal Philips (NYSE: PHG) (AEX: PHIA), a global leader in health technology, today released a new Future Health Index (FHI) report " Moving data to the heart of health systems: Increasing vital technology adoption to make value-based healthcare a reality

PULSUS Group collaborates with Anbu Kochi to Contribute towards Kerala Flood Heathcare—20 Sep 18

In a humanitarian effort, PULSUS Group - in collaboration with Anbu Kochi - is responding to the calamity of the recent, unprecedented floods in the Indian state of Kerala by providing contributions to aid relief and rehabilitation measures. PULSUS Group

Menarini Ricerche Announces New Positive Results in Acute Myeloid Leukemia Cell Lines for Heathcare—19 Sep 18

Menarini Ricerche will present tomorrow, September 20th, at the 60th Annual Meeting of the Italian Cancer Society (SIC), new preclinical data showing that pre-treatment with 5-Azacytidine and Decitabine enhances the Antibody-dependent cellular

Experts Call for Improved Identification of #High Burden# Rosacea Patients in Everyday Heathcare—17 Sep 18

- Additional analysis of global survey data reveals quality of life is impacted by several factors extending beyond severity of rosacea alone Additional analysis of a global survey conducted and presented earlier this year, as an expert-authored report

BookDoc collaborates with Chow Tai Fook: Get more rewards by staying active together with Chow Tai Heathcare—17 Sep 18

Chow Tai Fook is collaborating with BookDoc, the largest integrated healthcare app in Southeast Asia by healthcare network in giving more rewards to BookDoc users for maintaining an active healthy lifestyle. Users can now enjoy discounts and redeem

MEDICAL WINGS THAILAND BASED AIR AMBULANCE OPERATOR ACHIEVES FULL ACCREDITATION FROM CAMTS AND Heathcare—13 Sep 18

Medical Wings, the air ambulance division of Siam Land Flying Company, a subsidiary company of Charoen Pokphand Group (C.P. Group), is proud to achieve full re-accreditation of its existing CAMTS approval as well as attaining the new CAMTS EU

Photo Release: CGH Group Hospital held the event Happy Life with Healthy Bone and Joints Seminar in Heathcare—12 Sep 18

CGH Group Hospital recently held a live health talk in Yangon, Myanmar to highlight the important health issues on bone and joints for all Myanmar people. A team of medical experts led by Dr. Wanchai Sirisereewan (4th from left), CGH's Orthopedic Surgeon

BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) Significantly Improved Progression-Free Survival Heathcare—12 Sep 18

- First positive Phase III immunotherapy trial in combination with a tyrosine kinase inhibitor (TKI) in any tumor type - Results significant in both PDL1+ and all-comer populations - Alliance plans to pursue a regulatory submission in the US and

Syneron Candela Announces Acquisition Of Ellipse Heathcare—06 Sep 18

- Acquisition of Danish Ellipse adds globally renowned IPL and laser technologies to Syneron Candela's portfolio, further strengthening their position in multi-application, multi-technology devices Syneron Candela, a leading global aesthetic device

ผลการทดลองสายสวนหลอดเลือดชนิดเคลือบยา Firehawk ได้รับการเผยแพร่ทางวารสารการแพทย์ The Heathcare—04 Sep 18

MicroPort Scientific Corporation (MicroPort(R), HK:0853) ประกาศว่า ผลการทดลองสายสวนหลอดเลือดชนิดเคลือบยา Firehawk(R) Rapamycin Target Eluting Coronary Stent System (Firehawk(R)) ภายใต้โครงการทดลองแบบสุ่มและมีกลุ่มควบคุมในศูนย์หลายแห่งในชื่อ TARGET AC

Olon Acquires Manufacturing Facility in India Heathcare—04 Sep 18

Olon S.p.A., a world leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, announced today the acquisition of a local generics chemical operations API manufacturing facility in

Firehawk Clinical Data From The TARGET AC European Clinical Trial Has Been Accepted For Publication Heathcare—04 Sep 18

MicroPort Scientific Corporation ("MicroPort(R)", HK:0853) announced today that the clinical trial results for its Firehawk(R) Rapamycin Target Eluting Coronary Stent System ("Firehawk(R)") which conducted a multi-center, randomized controlled trial

Ozempic(R) Consistently Reduced the Risk of Major Cardiovascular Events Across Type 2 Diabetes Heathcare—27 Aug 18

Ozempic(R) (semaglutide) consistently reduced the risk of the composite outcome of time to first occurrence of non-fatal heart attack, non-fatal stroke or cardiovascular death (collectively termed major adverse cardiovascular events, MACE) in people with

Singapore#s first clinical trial approval for T cell engineered (TCR) immunotherapy for treatment Heathcare—20 Aug 18

Lion TCR Pte. Ltd., a Singapore-based Biotech company receives approval from Health Sciences Authority (HSA), Singapore, for its Phase I/II multicentre clinical study of its product candidate (LioCyx(TM)) for treatment of relapsed liver cancer post-liver

Merck Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Heathcare—16 Aug 18

- Patent covers paired Cas9 nickase technology to reduce off-target effects, advance gene therapy and research - Expands company's foundational CRISPR cutting and integration IP necessary to correct genetic defects in gene therapy patients - Merck to

Kaneka officially starts continuous manufacturing under GMP Heathcare—14 Aug 18

Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Mamoru Kadokura) have installed continuous manufacturing equipment to be applied to pharmaceutical products at Kaneka Singapore Co. (Pte.) Ltd, (Headquarters: Singapore; President: Kazuhiko

TIENS Group opens new high-tech Experience Store in Shenzhen Heathcare—09 Aug 18

TIENS Group, one of leading corporations in the Healthcare industry, unveiled a new high-tech Customer Experience Store in Shenzhen. Li Jinyuan, founder and chairman of TIENS group, announced the official opening of its first store in the world on August

Sotera Health#s Nordion completes the sale of its medical isotopes business to Heathcare—07 Aug 18

- Nordion's increased focus on gamma technologies supports Sotera Health's company-wide commitment to Safeguarding Global Health(TM) Sotera Health LLC, the world's leading, fully integrated protector of global health, today announced the closing of the

Menarini Ricerche to Sponsor Cancer Trial in Acute Myeloid Leukemia in Heathcare—06 Aug 18

Menarini Ricerche, a company of the Menarini Group, announced today that the sponsorship of the ongoing Phase I/II study that is investigating MEN1703/SEL24 for the treatment of patients with relapsed/refractory (R/R) AML in the USA has been transferred

Britannia Pharmaceuticals Ltd เผยผลการศึกษา TOLEDO เฟส 3 ชี้การใช้ยา Apomorphine Heathcare—06 Aug 18

บริษัท Britannia Pharmaceuticals Ltd ได้เผยแพร่ผลการศึกษา TOLEDO (Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's Disease) แบบให้ยาจริงกับยาหลอกกับคนไข้ (double-blind phase) ในนิตยสาร Lancet

Britannia Pharmaceuticals Ltd: Phase 3 TOLEDO Study Shows Apomorphine Infusion Provides Effective Heathcare—06 Aug 18

Britannia Pharmaceuticals Ltd has announced publication of the results of the double-blind phase of the TOLEDO study in Lancet Neurology[1]. Treatment with APO-go(R)/MOVAPO(R) (apomorphine) subcutaneous infusion for 12 weeks gave significantly greater

Humanscape to Build the Finest Blockchain-based Patient Network in Heathcare—02 Aug 18

- Direct sharing of symptoms and treatment processes and provision of compensation for the sharing of information. - Expected to release blockchain-based "Humanscape" later this year. Today, more and more people are suffering from serious, incurable,

Immune Advisors Publishes Peer-Reviewed Study Demonstrating Efficacy of a Probiotic and Digestive Heathcare—02 Aug 18

Immunotherapy Focused Consulting Company Provides Independent Support of the Value of Daily Body Restore (R) for Cancer Patients Immune Advisors, LLC, a California-based company focused on forming, financing, and growing companies in the immunotherapy

Boehringer Ingelheim achieves modest growth in the first half of 2018 Heathcare—01 Aug 18

In the first half of 2018, Boehringer Ingelheim made important advances in the research and development area and thereby further strengthened its basis for developing new medical breakthroughs for patients. Of some 80 development projects, 65 per cent